See also this year's filing and all EDGAR filings for this company.
PDF Report 0000315545_2026_Provectus_Biopharmaceuticals_INC.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000315545, Provectus Biopharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 567,874 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,000 |
| 3 | remainder_Assets | 126,628 |
| 4 | LiabilitiesCurrent | 6,897,378 |
| 5 | LiabilitiesNoncurrent | 79,221 |
| 6 | remainder_Liabilities | 23,621 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 3,773,579 |
| 9 | ResearchAndDevelopmentExpense | 1,891,131 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 417,299 |
| 12 | remainder_NetIncome | -210,511 |
| 13 | remainder_ComprehensiveNetIncome | 449,539 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 697,502 |
| 1 | Liabilities | 7,000,220 |
| 2 | Expenses | 5,664,710 |
| 3 | Revenues | 417,299 |
| 4 | StockholdersEquity | -6,302,718 |
| 5 | NetIncome | -5,457,922 |
| 6 | ComprehensiveNetIncome | -5,233,152 |
| 7 | BaseVar | 7,219,890 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -4.93 |
| 9 | EconomicCapitalRatio | 0.202 |
Edgar->Model Mapping
Feature Distribution
Change over Time
